Lacosamide Tablet, Film Coated
Product Images NDC 80425-0510

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 80425-0510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lacosamide 50mg #30 (Lacosamide 50mg 80425 0510 01)

This is a prescription label for Lacosamide 50mg tablets, with a total of 30 tablets in the bottle. The medication is compared to VIMPAT. The lot number and expiration date are indicated. The tablets should be stored at a temperature between 20°C to 25°C (60°F to 77°F) and the packaging information includes the manufacturer and distributor details.*

FDA Label Image

Lacosamide 50mg #60 (Lacosamide 50mg 80425 0510 02)

FDA Label Image

Lacosamide 50mg #90 (Lacosamide 50mg 80425 0510 03)

Description: This is information related to Lacosamide 50mg tablets stored at 20°C-25°C. The tablets come in a pack of 90 and are comparable to Vimpat. Details include the NDC numbers for the product source and the lot number with an expiration date of 12/31/2026. The text also mentions a serial number and instructions for storage and use.*

FDA Label Image

Laco-fig1.jpg (Laco Fig1)

The text provides a visualization labeled as Figure 1, showing the median percent reduction in seizure frequency per 28 days from Baseline to the Maintenance Phase based on different doses. The graph seems to be comparing the reduction in seizure frequency between different dose levels of a medication called Lacosamide. It indicates statistical significance compared to a placebo.*

FDA Label Image

Laco-fig2.jpg (Laco Fig2)

This document shows information on the Responder Rate for Lacosamide and Placebo groups in Studies 2, 3, and 4. It includes a chart depicting the proportion of patients in each group. The data is presented in percentages, comparing different dosage levels of Lacosamide against Placebo.*

FDA Label Image

Laco-fig3-a (Laco Fig3 A)

This appears to be a statistical evaluation of a medication called Lacosamide on patients, showing a risk reduction of 45.2% with a p-value of 0.001. The graph displays the proportion of patients affected by the medication and provides confidence intervals for the results. The study included 118 patients with significant findings related to the impact of Lacosamide.*

FDA Label Image

Laco-str (Laco Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.